Table 3. Association of History of Depressive Symptoms, Self-reported Physician Diagnosis of Depression, and Antidepressant Use With Incident SLE in the NHS and NHS II, 1992-2013.
Variable | SLE Cases, No. | Person-Yearsa | Hazard Ratio (95% CI) | |
---|---|---|---|---|
Model 1b | Model 2c | |||
Depressive symptoms (MHI-5) | ||||
No depression (MHI-5 score ≥60) | 99 | 2 793 212 | 1 [Reference] | 1 [Reference] |
Probable depression (MHI-5 score <60) | 43 | 694 391 | 1.70 (1.18-2.44)d | 1.60 (1.11-2.31)e |
Diagnosis of depression | ||||
No diagnosis | 59 | 2 148 617 | 1 [Reference] | 1 [Reference] |
Diagnosis | 20 | 366 539 | 2.19 (1.29-3.71)d | 1.91 (1.12-3.26)e |
Antidepressant use | ||||
No use | 93 | 2 703 408 | 1 [Reference] | 1 [Reference] |
Use | 40 | 431 991 | 2.80 (1.94-4.05)f | 2.47 (1.70-3.60)f |
Sensitivity analysis 1, depressive symptoms with more stringent MHI-5 cutoff | ||||
No depression (MHI-5 score ≥52) | 117 | 3 175 548 | 1 [Reference] | 1 [Reference] |
Probable depression (MHI-5 score <52) | 22 | 219 142 | 2.29 (1.45-3.64)d | 2.17 (1.37-3.46)d |
Sensitivity analysis 2, censoring women at first antidepressant use | ||||
No depression | 61 | 2 184 815 | 1 [Reference] | 1 [Reference] |
Depression diagnosis or MHI-5 score <60 | 26 | 452 061 | 2.11 (1.32-3.38)d | 2.04 (1.27-3.26)d |
Sensitivity analysis 3, association with antidepressant type | ||||
No antidepressant use | 93 | 2 704 188 | 1 [Reference] | 1 [Reference] |
SSRI use | 26 | 289 937 | 2.96 (1.88-4.64)f | 2.63 (1.66-4.14)f |
Tricyclic or other antidepressant use | 12 | 118 695 | 3.19 (1.72-5.93)f | 2.86 (1.53-5.31)f |
Sensitivity analysis 4, stratified by dsDNA antibody status | ||||
Anti-dsDNA antibody–positive SLE | ||||
No depression | 33 | 2 529 872 | 1 [Reference] | 1 [Reference] |
Depression | 42 | 1 140 243 | 2.58 (1.66-3.99)f | 2.28 (1.46-3.56)f |
Anti-dsDNA antibody–negative SLE | ||||
No depression | 36 | 2 529 748 | 1 [Reference] | 1 [Reference] |
Depression | 34 | 1 140 158 | 2.50 (1.54-4.06)f | 2.30 (1.41-3.75)f |
Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); dsDNA, double-stranded DNA; MHI-5, 5-item Mental Health Inventory; NHS, Nurses’ Health Study; SLE, systemic lupus erythematosus; SSRI, serotonin reuptake inhibitor.
Person-years differ in models because each measure was first queried in a different year; person-time prior to the first query was excluded.
Adjusted for race and age.
Adjusted for time-updated BMI, cigarette smoking, and oral contraceptive and postmenopausal hormone use.
P < .01.
P < .05.
P < .001.